Home › Calculator › MANE Dividend Calculator 2026
MANE Dividend DRIP Calculator 2026
2.02% YieldHealthcareVeradermics, Incorporated · NYSE
Price: $99.05 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MANE pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MANE snowball 📈
$10,000 in MANE → $12.2K in 10 years · $20.14/month
About Veradermics, Incorporated (MANE) — Dividend Analysis 2026
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
Compare MANE with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MANE DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MANE position with:
🌍 MANE Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MANE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.02% | -0.78% | $202 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.72% | -1.08% | $172 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.62% | -1.18% | $162 / yr |
| 🇬🇧 UK ISA | 0% | 2.02% | -0.78% | $202 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.84% | -0.96% | $184 / yr |
| 🇨🇦 TFSA | 0% | 2.02% | -0.78% | $202 / yr |
| 🇨🇦 CA Taxable | 25% | 1.52% | -1.28% | $152 / yr |
| 🇦🇺 Super (pension) | 15% | 1.72% | -1.08% | $172 / yr |
| 🇦🇺 AU Taxable | 30% | 1.41% | -1.39% | $141 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.49% | -1.31% | $149 / yr |
| 🇫🇷 FR Taxable | 30% | 1.41% | -1.39% | $141 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MANE Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MANE Dividend Payment Schedule
MANE pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MANE vs Healthcare Benchmarks
How MANE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MANE sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MANE Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MANE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Veradermics, Incorporated (MANE) is currently trading at $99.05, 23% below its 52-week high. The current dividend yield is 2.02% based on an annual payout of $2.00 per share.
MANE (Veradermics, Incorporated) — 2.02% Dividend Yield Analysis
Veradermics, Incorporated (MANE) is a healthcare stock currently trading at $99.05 with a dividend yield of 2.02%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MANE News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.